InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
3
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-32.7%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by DOUGLAS RICHARD, Director. Director active across 2 companies, notably NOVAVAX INC. Aggregated, 13 filings have been logged. Split: 3 buys · 0 sell. Total volume traded: €713k. History available since 22 November 2021. The latest transaction was filed on 12 June 2024 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations13 total
18,880 sharesCommon StockSEC:0001104659-26-076927:0
30,421 sharesCommon StockSEC:0000905148-26-003053:0
6,670 shares0Common StockSEC:0001593968-24-000863:0
21,367 shares0Common StockSEC:0001415889-24-016715:0
3,100 sharesCommon StockSEC:0001209191-23-036744:0
80,000 shares@ US$4.318544.7% of flowCommon StockSEC:0001209191-23-021573:0
Ideal exit: 24 Dec 2023 (T+270)
700 sharesCommon StockSEC:0001209191-22-038592:0
1,500 shares@ US$25.600.0023% mcap50.0% of flowCommon StockSEC:0001209191-21-069798:0
1,500 shares@ US$25.6050.0% of flowCommon StockSEC:0001209191-21-069798
20,000 shares@ US$11.1227.7% of flowCommon StockSEC:0001209191-21-066289
Ideal exit: 19 Aug 2022 (T+270)
20,000 shares@ US$11.120.18% mcap50.0% of flowCommon StockSEC:0001209191-21-066289:0
Ideal exit: 19 Aug 2022 (T+270)
3,450 sharesCommon StockSEC:0001209191-21-043700
3,450 sharesCommon StockSEC:0001209191-21-043700:0
13 of 13 declarations
About DOUGLAS RICHARD
Richard Douglas is a Board Member at Novavax Inc and MaxCyte, Inc. In this role, he contributes to the governance of both companies by bringing his expertise in the biopharmaceutical sector. Richard plays a key role in evaluating performance and overseeing growth strategies. His industry experience is a valuable asset to the management teams of Novavax and MaxCyte.
